Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Surgical ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- 2nd edition. WHO classification of breast tumours: WHO classification of tumours. vol. 2. IARC, Lyon, France2019 (Who Classification of Tumours Editorial Board)
- A prospective study of benign breast disease and the risk of breast cancer.JAMA. 1992; 267: 941-944
- Atypical hyperplastic lesions of the female breast: a long-term follow-up study.Cancer. 1985; 55: 2698-2708
- The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ.Breast Cancer Res. 2003; 5: 258-262
- Neoplastic diseases: a textbook on tumors.WB Saunders, Philadelphia1919
- Lobular carcinoma in situ. A rare form of mammary cancer.Am J Pathol. 1941; 17: 491-496
- Lobular neoplasia (so-called lobular carcinoma in situ) of the breast.Cancer. 1978; 42: 737-769
- Lobular Carcinomas In Situ Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma.Clin Cancer Res. 2019; 25: 674-686
- Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions.Breast Cancer Res. 2012; 14: R103
- Clonal relationships between lobular carcinoma in situ and other breast malignancies.Breast Cancer Res. 2016; 18: 66
- National Comprehensive Cancer Network. Breast Cancer Screening and Diagnosis.(Available at:) (Accessed April 1, 2022)
- Combined histologic and cytologic criteria for the diagnosis of mammary atypical ductal hyperplasia.Hum Pathol. 1992; 23: 1095-1097
- Atypical ductal hyperplasia: interobserver and intraobserver variability.Mod Pathol. 2011; 24: 917-923
- Lobular carcinoma in situ.in: Board T.W.C.E. Breast Tumours. International Agency for Research on Cancer, Lyon (France)2019: 71-74
- Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.Am J Surg Pathol. 2009; 33: 1683-1694
- Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry.Am J Surg Pathol. 2013; 37: 1-11
- Lobular carcinoma in situ of the breast: clinical, pathologic, and mammographic features.AJR Am J Roentgenol. 1991; 157: 257-265
- The radiological features, diagnosis and management of screen-detected lobular neoplasia of the breast: Findings from the Sloane Project.Breast. 2016; 27: 109-115
- Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation.Hum Pathol. 1992; 23: 655-662
- Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.Mod Pathol. 2002; 15: 1044-1050
- Florid lobular intraepithelial neoplasia with signet ring cells, central necrosis and calcifications: a clinicopathological and immunohistochemical analysis of ten cases associated with invasive lobular carcinoma.Arch Med Res. 2010; 41: 436-441
- Pleomorphic and florid lobular carcinoma in situ variants of the breast: a clinicopathologic study of 85 cases with and without invasive carcinoma from a single academic center.Am J Surg Pathol. 2019; 43: 399-408
- Breast cancer precursors revisited: molecular features and progression pathways.Histopathology. 2010; 57: 171-192
- E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast.Mod Pathol. 2005; 18: 741-751
- Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E-cadherin and catenin expression and microsatellite instability.Int J Cancer. 2003; 106: 208-215
- Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.Cancer Cell. 2006; 10: 437-449
- The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type.J Pathol. 2010; 220: 45-57
- Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia.Cancer Res. 1998; 58: 4721-4727
- Comprehensive molecular portraits of invasive lobular breast cancer.Cell. 2015; 163: 506-519
- APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity.Cancer Discov. 2015; 5: 704-712
- Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988–2001.Cancer. 2006; 106: 2104-2112
- Gene expression profiling in breast cancer: classification, prognostication, and prediction.Lancet. 2011; 378: 1812-1823
- Risk factors for breast cancer in women with proliferative breast disease.N Engl J Med. 1985; 312: 146-151
- Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.N Engl J Med. 1999; 340: 77-84
- Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease.Hum Pathol. 1991; 22: 1232-1239
- Lobular Carcinoma in Situ: A 29-Year Longitudinal Experience Evaluating Clinicopathologic Features and Breast Cancer Risk.J Clin Oncol. 2015; 33: 3945-3952
- Lobular neoplasia. Long term risk of breast cancer and relation to other factors.Cancer. 1996; 78: 1024-1034
- Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: Analysis of Surveillance, Epidemiology, and End Results data.J Clin Oncol. 2005; 23: 5534-5541
- Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies.Cancer. 2016; 122: 515-520
- Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women.Cancer. 2016; 122: 2971-2978
- The Tyrer-Cuzick Model Inaccurately Predicts Invasive Breast Cancer Risk in Women With LCIS.Ann Surg Oncol. 2020; 27: 736-740
- Assessment of the accuracy of the Gail model in women with atypical hyperplasia.J Clin Oncol. 2008; 26: 5374-5379
- Lobular carcinoma in situ of the breast.Breast J. 1999; 5: 296-303
- Management of lobular carcinoma in-situ and atypical lobular hyperplasia of the breast: A review.Eur J Surg Oncol. 2011; 37: 279-289
- Trends in incidence and management of lobular carcinoma in situ: A population-based analysis.Ann Surg Oncol. 2013; 20: 3240-3246
- The American Society of Breast Surgeons. Position Statement on Screening Mammography.(Available at:) (Assessed April 1, 2022)
- Atypical lobular hyperplasia and classic lobular carcinoma in situ in core biopsy specimens: routine excision is not necessary.Mod Pathol. 2008; 21: 1208-1216
- The significance of lobular neoplasia on needle core biopsy of the breast.Virch Arch. 2008; 452: 473-479
- Management of in situ lobular neoplasia detected on needle core biopsy of breast.J Clin Pathol. 2010; 63: 987-993
- Is excisional biopsy required after a breast core biopsy yields lobular neoplasia?.AJR Am J Roentgenol. 2012; 199: 929-935
- Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.Ann Surg Oncol. 2012; 19: 914-921
- Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy.Ann Surg Oncol. 2012; 19: 3131-3138
- Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation.Radiology. 2013; 269: 340-347
- Classic lobular neoplasia on core biopsy: a clinical and radio-pathologic correlation study with follow-up excision biopsy.Mod Pathol. 2013; 26: 762-771
- Classic lobular carcinoma in situ and atypical lobular hy- perplasia at percutaneous breast core biopsy: outcomes of prospective excision.Cancer. 2013; 119: 1073-1079
- Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.Mod Pathol. 2016; 29: 1471-1484
- Incidence of adjacent synchronous invasive carcinoma and/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020).Ann Surg Oncol. 2016; 23: 722-728
- Core breast biopsies showing lobular carcinoma in situ should be excised and surveillance is reasonable for atypical lobular hyperplasia.AJR Am J Roentgenol. 2016; 207: 1132-1145
- Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases.Clin Breast Cancer. 2016; 16: 507-513
- Isolated atypical lobular hyperplasia diagnosed on breast biopsy: low upgrade rate on subse- quent excision with long-term follow-up.Arch Pathol Lab Med. 2018; 142: 391-395
- Observation versus excision of lobular neoplasia on core needle biopsy of the breast.Breast Cancer Res Treat. 2018; 168: 649-654
- Triaging Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ on Percutaneous Core Biopsy to Surgery or Observation: Assiduous Radiologic-Pathologic Correlation Works, Quantitating Extent of Disease Does Not.Arch Pathol Lab Med. 2019; 143: 621-627
- Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high risk breast lesion conferences at an academic institution. Breast cancer research and.treatment. 2021; 185: 573-581
- Upgrade at excisional biopsy after a core needle biopsy diagnosis of classic lobular carcinoma in situ.Surgery. 2021; 169: 644-648
- Atypical Lobular Hyperplasia and Classic Lobular Carcinoma In Situ Can Be Safely Managed Without Surgical Excision.Ann Surg Oncol. 2022; 29: 1660-1667
- Evaluating the rate of upgrade to invasive breast cancer and/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ.Ann Surg Oncol. 2019; 26: 55-61
- Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.Mod Pathol. 2021; 34: 1495-1506
- Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management.Ann Surg Oncol. 2015; 22: 4263-4269
- Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ.Arch Pathol Lab Med. 2011; 135: 737-743
- Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications.Arch Pathol Lab Med. 2010; 134: 1024-1028
- Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.Am J Surg Pathol. 2008; 32: 1721-1726
- Breast surgeon’s survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ.Breast J. 2013; 19: 116-118
- Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast conservation therapy.Int J Radiat Oncol Biol Phys. 1998; 40: 353-358
- Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases.Histopathology. 2014; 64: 981-993
- Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.J Am Coll Radiol. 2018; 15: 408-414
- American Cancer Society. Lobular Carcinoma in Situ.(Available at:) (Accessed April 1, 2022)
- MRI surveillance for women with dense breasts and a previous breast cancer and/or high risk lesion.Breast. 2017; 34: 77-82
- Is there a role for routine screening MRI in women with LCIS?.Breast Cancer Res Treat. 2013; 142: 445-453
- BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials.Clin Cancer Res. 2007; 13: 7357-7362
- Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.J Natl Cancer Inst. 1998; 90: 1371-1388
- Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.JAMA. 2006; 295: 2727-2741
- Exemestane for breast-cancer prevention in postmenopausal women.N Engl J Med. 2011; 364: 2381-2391
- IBIS-II investigators. Use of anastrozole for breast cancer prevention (IBIS-II): long-term results of a randomised controlled trial.Lancet. 2020; 395: 117-122
- A survey among breast cancer specialists on the low uptake of therapeutic prevention with tamoxifen or raloxifene.Cancer Prev Res (Phila). 2018; 11: 38-43
- Symptoms and QOL as predictors of chemoprevention adherence in NRG Oncology/NSABP Trial P-1.J Natl Cancer Inst. 2015; 108: djv365
- Patient decisions about breast cancer chemoprevention: a systematic review and meta-analysis.J Clin Oncol. 2010; 28: 3090-3095
- Patient reluctance toward tamoxifen use for breast cancer primary prevention.Ann Surg Oncol. 2001; 8: 580-585
- Barriers to the use of breast cancer risk reduction therapies.J Natl Compr Canc Netw. 2015; 13: 927-935
- A System-Level Approach to Improve the Uptake of Antiestrogen Preventive Therapy among Women with Atypical Hyperplasia and Lobular Cancer In Situ.Cancer Prev Res. 2018; 11: 295-302
- Randomized Placebo Controlled Trial of Low-Dose Tamoxifen to Prevent Local and Contralateral Recurrence in Breast Intraepithelial Neoplasia.J Clin Oncol. 2019; 37: 1629-1637
- Surgical Management of Lobular Carcinoma In Situ: Analysis of the National Cancer Database.Ann Surg Oncol. 2018; 25: 2229-2234
- A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.Arch Intern Med. 2005; 165: 516-520
- Long-term follow-up of nipple-sparing mastectomy without radiotherapy: a single center study at a Japanese institution.Med Oncol. 2013; 30: 481
- Oncologic Safety of Prophylactic Nipple-Sparing Mastectomy in a Population With BRCA Mutations: A Multi-institutional Study.JAMA Surg. 2018; 153: 123-129
- Textbook of complex general surgical oncology.McGraw-Hill, New York, USA2016
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
